A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...
After announcing it would start selling its assets earlier this year and lay off nearly half the company, the medical app developer Akili Interactive has found a willing buyer. Virtual Therapeutics, ...
Digital therapeutics company Akili is planning to merge with Virtual Therapeutics. Upon closing, the combined organization would operate as privately held Virtual Therapeutics, with Akili as a wholly ...
BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTC Ⓡ (AKL-T01) as an over-the ...
The Roblox vision for bringing people together through shared experiences, plus the Akili commitment to a new era of cognitive medicine, make the companies ideal partners to deliver a reimagined ...
Last year, Akili Interactive received FDA clearance for the first game-based treatment to improve attention in children with ADHD. Now, the digital health startup is testing if the same technology ...
Akili said that EndeavorOTC has been authorized by the Food and Drug Administration as an over-the-counter treatment for adults with attention-deficit/hyperactivity ...
The team at Akili describes its ethos on its website as “establishing a new era of cognitive medicine.” The company writes it “[believes] effective medicine can also be fun and engaging [by] creating ...
A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback